GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NGL Fine-Chem Ltd (BOM:524774) » Definitions » Deferred Tax

NGL Fine-Chem (BOM:524774) Deferred Tax : ₹0 Mil (TTM As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is NGL Fine-Chem Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

NGL Fine-Chem's change in deferred tax for the three months ended in Mar. 2024 was ₹0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0 Mil.

NGL Fine-Chem Deferred Tax Historical Data

The historical data trend for NGL Fine-Chem's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NGL Fine-Chem Deferred Tax Chart

NGL Fine-Chem Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

NGL Fine-Chem Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

NGL Fine-Chem Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NGL Fine-Chem Deferred Tax Related Terms

Thank you for viewing the detailed overview of NGL Fine-Chem's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

NGL Fine-Chem (BOM:524774) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NGL Fine-Chem Ltd (BOM:524774) » Definitions » Deferred Tax
Comparable Companies
BOM:524280 BOM:532815 BOM:507747 BOM:543500 NSE:MARKSANS LLY JNJ MRK ABBV XSWX:ROG LSE:AZN XSWX:NOVN PFE AMGN XPAR:SAN BMY GILD LSE:GSK TSE:4568 TSE:4519
Traded in Other Exchanges
NGLFINE:India
Address
301, E Square, Subhash Road, Vile Parle (East), Mumbai, MH, IND, 400057
Website
https://www.nglfinechem.com
NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. The company is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. Its product includes Active Pharmaceutical Ingredients (APIs) animal health, APIs human health, Intermediates and Finished dosage form, of which maximum revenue is generated from Veterinary APIs. Its geographical segments include India, Europe, Asia Pacific, United States, and Rest of the world. The Group's business activities fall within a single business segment of pharmaceuticals.

NGL Fine-Chem (BOM:524774) Headlines

No Headlines